Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Ergun Velidedeoglu"'
Autor:
Elektra J. Papadopoulos, Stephen R. Karpen, Teun van Gelder, Nicole Spear, Ozlem Belen, C. Alex Page, Michelle Campbell, Amanda Klein, Inish O’Doherty, Renata Albrecht, Rita R. Alloway, Matthew J Everly, Paul G. Kluetz, Lori M. Minasian, Ergun Velidedeoglu, Sandra A. Mitchell, Ruth Sapir-Pichhadze
Publikováno v:
Transplantation, 105(5), 941-944. Lippincott Williams & Wilkins
Publikováno v:
Transplantation. 102:e257-e264
Despite major advances in understanding the pathophysiology of antibody-mediated rejection (AMR); prevention, diagnosis and treatment remain unmet medical needs. It appears that early T cell-mediated rejection, de novo donor-specific antibody (dnDSA)
Autor:
Ali Naji, Richard Hasz, Ergun Velidedeoglu, Roy D. Bloom, J. Abrams, Marty T. Sellers, Adam M. Frank, Allyson B. Kass, James F. Markmann, Robert A. Grossman, Howard M. Nathan, Joseph W. Markmann
Publikováno v:
Transplantation. 78:1670-1675
BACKGROUND Expanded-criteria donor (ECD) kidneys are associated with a higher risk of posttransplant failure, but they remain a favorable alternative to dialysis. Now that a uniform definition of "expanded criteria" exists, it is more appropriate tha
Autor:
Ergun Velidedeoglu, Rajender Reddy, Adam M. Frank, Peter L. Abt, Joseph W. Markmann, James F. Markmann, Kevin C. Mange, Niraj M. Desai
Publikováno v:
Transplantation. 77:1834-1842
Background Survival following liver transplantation for hepatitis C virus (HCV) is significantly poorer than for liver transplants performed for other causes of chronic liver disease. The factors responsible for the inferior outcome in HCV+ recipient
Autor:
Brigitte Koeberlein, James F. Markmann, Ergun Velidedeoglu, Nicolai M. Doliba, Xiaolun Huang, Franz M. Matschinsky, Moh Moh Lian, Adam M. Frank, Marko Z. Vatamaniuk, Ali Naji, Niraj M. Desai, Clyde F. Barker, Bryan A. Wolf, Shaoping Deng
Publikováno v:
Diabetes. 53:624-632
Type 2 diabetic subjects manifest both disordered insulin action and abnormalities in their pancreatic islet cells. Whether the latter represents a primary defect or is a consequence of the former is unknown. To examine the β-cell mass and function
Autor:
Niraj M. Desai, Kevin C. Mange, James F. Markmann, William C. Chapman, Ergun Velidedeoglu, Joseph W. Markmann, Peter L. Abt, Michael D. Crawford, Adam M. Frank
Publikováno v:
Transplantation. 77:99-106
Background The Model for End-Stage Liver Disease (MELD) has been found to accurately predict pretransplant mortality and is a valuable system for ranking patients in greatest need of liver transplantation. It is unknown whether a higher MELD score al
Autor:
Nicolai M. Doliba, Ewan Bell, Xiaolun Huang, Adam M. Frank, Kenneth L. Brayman, James F. Markmann, Ergun Velidedeoglu, Eileen Markmann, Ali Naji, Niraj M. Desai, Chengyang Liu, Bryan A. Wolf, Franz M. Matschinsky, Shaoping Deng, Clyde F. Barker, Moh Moh Lian, Marko Vitamaniuk
Publikováno v:
Transplantation. 75:1423-1429
Recent improvements in isolated islet transplantation indicate that this therapy may ultimately prove applicable to patients with type I diabetes. An obstacle preventing widespread application of islet transplantation is an insufficient supply of cad
Vulnerability of allografts to rejection by MHC class II-restricted T-cell receptor transgenic mice1
Autor:
Ergun Velidedeoglu, Daniel J. Moore, Andrew L. Singer, Moh Moh Lian, Niraj M. Desai, Joseph W. Markmann, Beth P. Jarrett, Xiaolun Huang, Major K. Lee, and James F. Markmann, Andrew J. Caton, Adam M. Frank, Shaoping Deng
Publikováno v:
Transplantation. 75:1415-1422
Background Examination of the in vivo activation and function of CD4+ T cells in response to allografts may advance our understanding of the rejection process. We analyzed the capacity of transgenic class II-restricted CD4 T cells to reject skin, car
Autor:
Karen Fox-Talbot, Barbara A. Wasowska, William M. Baldwin, Melek M. Erdinc Sunay, Ergun Velidedeoglu
Background Alloantibody can contribute significantly to rejection of heart transplants by activation of complement and interactions with a variety of effector cells, including macrophages and monocytes through activating FcγRI, FcγRIII, FcγRIV, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0698c96f58e9a60be5167928d413058
https://europepmc.org/articles/PMC3795861/
https://europepmc.org/articles/PMC3795861/
Autor:
Karen Fox-Talbot, Kazunori Murata, Jinhuan Liu, Melek M. Erdinc, Justin W. Garyu, Ergun Velidedeoglu, Barbara A. Wasowska, William M. Baldwin, Sahar Lotfi-Emran, Chih Yuan Lee
Publikováno v:
Transplantation. 84(10)
Background Antibody-mediated rejection is characterized by macrophage margination against vascular endothelium. The potential interactions triggered by antibodies between endothelial cells (EC) and macrophages have not been examined thoroughly in tra